Buergel, Thore http://orcid.org/0000-0003-1159-007X
Steinfeldt, Jakob
Ruyoga, Greg
Pietzner, Maik
Bizzarri, Daniele http://orcid.org/0000-0002-6881-273X
Vojinovic, Dina
Upmeier zu Belzen, Julius http://orcid.org/0000-0002-0966-4458
Loock, Lukas
Kittner, Paul
Christmann, Lara
Hollmann, Noah http://orcid.org/0000-0001-8556-518X
Strangalies, Henrik
Braunger, Jana M.
Wild, Benjamin http://orcid.org/0000-0002-7492-8448
Chiesa, Scott T. http://orcid.org/0000-0003-4323-2189
Spranger, Joachim http://orcid.org/0000-0002-8900-4467
Klostermann, Fabian
van den Akker, Erik B. http://orcid.org/0000-0002-7693-0728
Trompet, Stella http://orcid.org/0000-0001-5006-0528
Mooijaart, Simon P.
Sattar, Naveed http://orcid.org/0000-0002-1604-2593
Jukema, J. Wouter http://orcid.org/0000-0002-3246-8359
Lavrijssen, Birgit
Kavousi, Maryam
Ghanbari, Mohsen http://orcid.org/0000-0002-9476-7143
Ikram, Mohammad A. http://orcid.org/0000-0003-0372-8585
Slagboom, Eline
Kivimaki, Mika http://orcid.org/0000-0002-4699-5627
Langenberg, Claudia
Deanfield, John
Eils, Roland http://orcid.org/0000-0002-0034-4036
Landmesser, Ulf http://orcid.org/0000-0002-0214-3203
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01ZZ1802A - 01ZZ1802Z)
Wellcome Trust (221854/Z/20/Z)
RCUK | Medical Research Council (MR/R024227/1)
Article History
Received: 2 November 2021
Accepted: 28 July 2022
First Online: 22 September 2022
Competing interests
: U.L. received grants from Bayer, Novartis and Amgen, consulting fees from Bayer, Sanofi, Amgen, Novartis and Daichy Sankyo and honoraria from Novartis, Sanofi, Bayer, Amgen and Daichy Sankyo. J.D. received consulting fees from GENinCode UK Ltd, honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk and Bayer and is Chief Medical Advisor to Our Future Health. R.E. received honoraria from Sanofi and consulting fees from Boehringer Ingelheim. All other authors declare no competing interests.